Xencor (XNCR) Total Liabilities (2013 - 2026)
Xencor's (XNCR) quarterly Total Liabilities came in at $221.2 million in Q1 2026, down 16.47% year-on-year from $264.8 million in Q1 2025, and down 7.79% on a QoQ basis from $239.9 million in Q4 2025.
Xencor (XNCR) Total Liabilities (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Total Liabilities data on file, last reported at $221.2 million in Q1 2026.
- On a quarterly basis, Total Liabilities fell 16.47% year-over-year to $221.2 million in Q1 2026; TTM through Mar 2026 was $221.2 million, a 16.47% decrease from a year earlier, with the FY2025 full-year figure at $239.9 million, down 13.68% from the prior year.
- Total Liabilities for Q1 2026 stood at $221.2 million, down from $239.9 million in the prior quarter.
- Over the last five years, Total Liabilities for XNCR reached as high as $303.0 million in Q4 2023 and fell as low as $94.9 million in Q1 2022.
- Historically, Total Liabilities has averaged $203.3 million across 5 years, with a median of $239.9 million in 2025.
- Across the five-year window, Total Liabilities jumped 194.13% in 2024 and decreased 17.17% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $118.8 million in 2022, then soared by 155.16% to $303.0 million in 2023, then fell by 8.29% to $277.9 million in 2024, then declined by 13.68% to $239.9 million in 2025, then retreated by 7.79% to $221.2 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $221.2 million in Q1 2026, $239.9 million in Q4 2025, and $243.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 221.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.21 Mn |
| Dec 31, 2025 | 239.91 Mn |
| Sep 30, 2025 | 243.50 Mn |
| Jun 30, 2025 | 259.07 Mn |
| Mar 31, 2025 | 264.82 Mn |
| Dec 31, 2024 | 277.92 Mn |
| Sep 30, 2024 | 293.98 Mn |
| Jun 30, 2024 | 291.91 Mn |
| Mar 31, 2024 | 297.12 Mn |
| Dec 31, 2023 | 303.05 Mn |
| Sep 30, 2023 | 109.42 Mn |
| Jun 30, 2023 | 99.25 Mn |
| Mar 31, 2023 | 119.83 Mn |
| Dec 31, 2022 | 118.77 Mn |
| Sep 30, 2022 | 112.57 Mn |
| Jun 30, 2022 | 108.98 Mn |
| Mar 31, 2022 | 94.90 Mn |
| Dec 31, 2021 | 104.71 Mn |
| Sep 30, 2021 | 78.40 Mn |
| Jun 30, 2021 | 48.66 Mn |